معرفی
Christopher Ross, MD, PhD, is a Professor of Psychiatry, Neurology, and Neuroscience at Johns Hopkins University and Director of the Division of Neurobiology. His research focuses on neurodegenerative and neuropsychiatric disorders, including Huntington’s disease (HD), Parkinson’s disease (PD), and schizophrenia. Ross leads a lab developing cellular and molecular models to study protein aggregation, gene transcription disruptions, and neurodegenerative pathways. Key projects include investigating huntingtin protein toxicity in HD, LRRK2 kinase activity in PD, and DISC1’s role in schizophrenia-related neuronal development.
His laboratory uses transgenic mouse models, biochemical techniques, and cell models to explore disease mechanisms. Notable contributions include identifying soluble huntingtin aggregates as toxic agents, demonstrating LRRK2’s role in PD pathogenesis, and linking DISC1 mutations to cortical migration defects. Ross collaborates with the Pharmacology and Neuroscience Training Programs at Johns Hopkins, fostering interdisciplinary research.
Recent work emphasizes therapeutic target discovery, such as inhibitors for mutant LRRK2 and compounds blocking huntingtin toxicity. His team also investigates protein interactions (e.g., Parkin-alpha-synuclein) to uncover shared pathways across neurodegenerative diseases. Ross’s publications span high-impact journals like Nature Neuroscience, Neuron, and Proceedings of the National Academy of Sciences.
Lab members include researchers like Jiang H, Liang Y, and international collaborators. Ross has trained numerous scientists in neurobiology, though specific advisee names are not listed in available texts. His work bridges basic science and clinical applications, aiming to translate molecular insights into novel therapies for devastating neurological conditions.
